Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
The research on bone-marrow transplantation mirrors the arc of many medical advancements. I was one of the early ...
The bill, named for a well-known Toronto hop hop artist and actor, received first reading in Queen’s Park on April 14 ...
Cancer treatments can take a toll on a person's body. A patient's treatment may cause nausea, changes in appetite, taste and ...
New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a ...
A new study led by researchers at Dartmouth Cancer Center pinpoints why many patients in rural areas experience delays in ...
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...
Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.
A comprehensive new review led by Mayo Clinic is helping shape how clinicians diagnose and treat meningioma, the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results